Development and implementation of an interdisciplinary pulmonary care clinic within an existing clinic program

Wheeler, James; Ray, Shaunta’ M.; Helmer, Robert S.; Stevens, Amy Barger; Franks, Andrea S.

doi:10.2146/ajhp140605

Cited by 3 publications

(2 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…There was a significant improvement in the patients' knowledge of their COPD following the APCOM programme, which was measured by the COPD-Q 32 . Increase in patients' COPD knowledge was also observed following an interdisciplinary programme to enhance management of asthma and COPD in primary care 33 . There was no significant change in the patients' perception of their multi-morbidity, or COPD in the context of multi-morbidity, following the programme.…”

Section: Discussionmentioning

confidence: 95%

Activating primary care COPD patients with multi-morbidity through tailored self-management support

Ansari

Hosseinzadeh

Dennis

et al. 2020

npj Prim. Care Respir. Med.

View full text Add to dashboard Cite

Given the dearth of COPD self-management interventions that specifically acknowledge multi-morbidity in primary care, we aimed to activate COPD patients through personalised self-management support that recognised the implications of co-morbidities. This single-group experimental study included patients aged 40−84 with a spirometry diagnosis of COPD and at least one co-morbidity. A self-management education programme for COPD in the context of multi-morbidity, based on the Health Belief Model, was tailored and delivered to participants by general practice nurses in face-to-face sessions. At 6 months' follow-up, there was significant improvement in patient activation (p < 0.001), COPD-related quality of life (p = 0.012), COPD knowledge (p < 0.001) and inhaler device technique (p = 0.001), with no significant change in perception of multi-morbidity (p = 0.822) or COPD-related multimorbidity (0.084). The programme improved patients' self-efficacy for their COPD as well as overall health behaviour. The findings form an empirical basis for further testing the programme in a large-scale randomised controlled trial.

show abstract

Section: Discussionmentioning

confidence: 95%

Activating primary care COPD patients with multi-morbidity through tailored self-management support

Ansari

Hosseinzadeh

Dennis

et al. 2020

npj Prim. Care Respir. Med.

View full text Add to dashboard Cite

show abstract

“…Examples include treatment of hypertension, anticoagulation, pulmonary clinics, and depression. [11][12][13][14][15][16][17][18][19] Pharmacists in various clinical emergency department roles have also been described. 20,21 Other reports have taken a broader approach with pharmacists managing multiple chronic diseases in the primary care setting such as hypertension, hyperlipidemia, diabetes, and metabolic syndrome.…”

Section: Introductionmentioning

confidence: 99%

Utilizing diagnostic pharmacists to support Family Medicine Walk-In clinics during the COVID-19 pandemic

McDermott¹

2022

Journal of the American Pharmacists Association

View full text Add to dashboard Cite

Background During the COVID19 pandemic, physician focus shifted from continuity of care to pandemic duties. However, patients still required in-person visits for acute or chronic complaints. Specially trained pharmacists were utilized to alleviate Family Medicine Walk-in (FMWI) provider shortages. Objective To describe the innovative practice utilizing diagnostic pharmacists in FMWI, evaluate their impact on provider time, compare workload to traditional advanced practice providers (APP), and evaluate type of visits and medications prescribed. Practice Description Pharmacists at an Indian Health Service medical center staffed FMWI 2.5 days per week to alleviate provider shortages during the COVID19 pandemic. The privileged pharmacist had a diagnostic scope like APPs. Non-privileged pharmacists provided care to patients utilizing current protocols and were required to present all new complaints to providers. Practice Innovation The facility utilized pharmacists that have completed, or progressing through, the local diagnostic training program to alleviate provider shortages. Evaluation Methods The absolute number of visits by pharmacists was determined and the number of provider hours shifted to pharmacy estimated. The number of visits by provider type was calculated and compared. ICD-10 codes were evaluated for purpose of visits. New prescriptions written by pharmacists were categorized and reimbursement rates determined. Results Pharmacists were responsible for 677 visits during 88 clinic days with an estimated 338 provider hours shifted to pharmacists. Pharmacists saw 5.8 patients per day, APPs 5.2, and physicians 5.7. Pharmacists primarily evaluated hypertension, diabetes, musculoskeletal, and infectious disease complaints. New prescription categories included pain management, endocrine, cardiovascular, and infectious disease. The single billable pharmacist was reimbursed $77,945. Conclusion Diagnostic pharmacists in FMWI have allowed providers to shift to other pandemic duties and demonstrate similar workload as APPs. Most visits and prescriptions fall within known pharmacist practice. Pharmacists in this setting pay for the existence of this position and remain integrated in FMWI.

show abstract

Interdisciplinary teams

Marcus-Aiyeku

2017

Nursing Management

View full text Add to dashboard Cite

Development and implementation of an interdisciplinary pulmonary care clinic within an existing clinic program

Cited by 3 publications

References 10 publications

Activating primary care COPD patients with multi-morbidity through tailored self-management support

Activating primary care COPD patients with multi-morbidity through tailored self-management support

Utilizing diagnostic pharmacists to support Family Medicine Walk-In clinics during the COVID-19 pandemic

Interdisciplinary teams

Contact Info

Product

Resources

About